NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American:ELMD) today announced the results of an independent, outcome-based clinical study presented during the third annual World ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of a peer-reviewed, retrospective outcomes study demonstrating ...
Provides patients with certain chronic lung conditions and retained secretions added comfort, user-friendly touch screen and unique garment design options Developed in consultation with clinicians and ...
Electromed is rated 'buy' due to accelerating growth, margin expansion, and a large underpenetrated bronchiectasis market. ELMD benefits from a new CMS rule and a recently approved bronchiectasis drug ...
NEW ORLEANS – A wearable oscillating vest, designed for treatment of cystic fibrosis, appeared to reduce chronic obstructive pulmonary disease (COPD) exacerbations, according to a retrospective study ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of a peer-reviewed, retrospective outcomes study demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results